NL-OMON35177已完成不适用
One-sequence, two-period, open-label study to evaluate the effects of FTY720 on the pharmacokinetics of an oral contraceptive (levonorgestrel/ethinyl estradiol) in healthy female volunteers. - FTY720D2114 OC interaction study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- ovartis
- 入组人数
- 31
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Female, 18-40 years of age, BMI 18-29 kg/m2, OC-user, healthy
排除标准
- •Clinical significant abnormalities during screening and baseline
研究者
相似试验
进行中（未招募）
不适用
Two-period, single-dose pharmacokinetic study in male adolescent patients with Fragile X Syndrome (FXS).Fragile X SyndromeMedDRA version: 14.0Level: PTClassification code 10017324Term: Fragile X syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2010-019353-18-Outside-EU/EEAovartis Pharma Services AG12
招募中
不适用
A Study to Evaluate the Effect of Gumiganghwaltang on the Pharmacokinetics of Caffeine after Oral Administration of Caffeine in Healthy Male VolunteersDiseases of th respiratory systemKCT0001812Kyung Hee University Oriental Medical Center8
已完成
不适用
An Open-label, Single-Sequence Study to Evaluate the Effects of Diltiazem, a Moderate CYP3A4/5 Inhibitor, on the Pharmacokinetics and Pharmacodynamics of E5555 and its Metabolites in Healthy Subjectscardiovascular eventsthrombosis10003216NL-OMON34620Eisai24
已完成
1 期
To determine whether a pharmacokinetic drug-drug interaction occurs between atorvastatin and elinogrel.chronic coronary heart disease (CHD)Cardiovascular - Coronary heart diseaseACTRN12611000315910ovartis Pharmaceutical Pty Limited28
已完成
不适用
An open-label, single-sequence study to investigate the effects of gastric acid suppression by Rabeprazole on the pharmacokinetics of BMS-986165 in healthy participantsPsoriasissystemic lupus erythematosus and Crohn's disease.10003816NL-OMON47975BritsolMyers Squibb Research and Development20